M. Kulyk & Associates, LLC Laboratory Corp Of America Holdings Transaction History

M. Kulyk & Associates, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$209.01 - $232.56 $320,412 - $356,514	1,533 Added 8.17%	20,295 $4.43 Million
Q4 2023 Feb 08, 2024	BUY	$197.69 - $227.29 $205,597 - $236,381	1,040 Added 5.87%	18,762 $4.26 Million
Q3 2023 Nov 07, 2023	BUY	$201.05 - $221.7 $721,367 - $795,459	3,588 Added 25.39%	17,722 $3.56 Million
Q2 2023 Aug 08, 2023	BUY	$211.93 - $241.33 $440,814 - $501,966	2,080 Added 17.26%	14,134 $3.41 Million
Q1 2023 May 08, 2023	BUY	$213.32 - $257.83 $203,293 - $245,711	953 Added 8.58%	12,054 $2.77 Million
Q4 2022 Feb 08, 2023	BUY	$203.72 - $248.97 $103,489 - $126,476	508 Added 4.8%	11,101 $2.61 Million
Q3 2022 Nov 07, 2022	BUY	$204.81 - $262.19 $2.17 Million - $2.78 Million	10,593 New	10,593 $2.17 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on M. Kulyk & Associates, LLC with notifications on news.